US7138486B2
(en)
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
US6849708B1
(en)
*
|
1986-05-05 |
2005-02-01 |
The General Hospital Corporation |
Insulinotropic hormone and uses thereof
|
US6380357B2
(en)
*
|
1997-12-16 |
2002-04-30 |
Eli Lilly And Company |
Glucagon-like peptide-1 crystals
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
WO2001000654A2
(en)
|
1999-06-29 |
2001-01-04 |
Pharmaceutical Discovery Corporation |
Purification and stabilization of peptide and proteins in pharmaceutical agents
|
KR20020073184A
(ko)
|
2000-01-27 |
2002-09-19 |
일라이 릴리 앤드 캄파니 |
글루카곤 유사 펩티드 1 화합물을 용해시키는 방법
|
US6844321B2
(en)
*
|
2000-01-31 |
2005-01-18 |
Novo Nordisk A/S |
Crystallization of a GLP-1 analogue
|
AU2001228327A1
(en)
*
|
2000-01-31 |
2001-08-14 |
Novo-Nordisk A/S |
Crystallisation of a glp-1 analogue
|
CA2380423A1
(en)
*
|
2000-05-17 |
2001-11-22 |
Bionebraska, Inc. |
Peptide pharmaceutical formulations
|
ATE424413T1
(de)
|
2000-06-16 |
2009-03-15 |
Lilly Co Eli |
Analoge des glucagon-ähnlichen peptids-1
|
JP2004521093A
(ja)
|
2000-12-13 |
2004-07-15 |
イーライ・リリー・アンド・カンパニー |
グルカゴン様インスリン刺激性ペプチドを用いる長期治療計画
|
AU2002228608A1
(en)
*
|
2000-12-13 |
2002-06-24 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
EP1412384B1
(de)
*
|
2001-06-28 |
2007-12-26 |
Novo Nordisk A/S |
Stabile formulierung von modifiziertem glp-1
|
EP1432730A4
(de)
*
|
2001-08-23 |
2006-10-11 |
Lilly Co Eli |
Analoga des glucagon-like peptide-1
|
EP2261250B1
(de)
|
2001-12-21 |
2015-07-01 |
Human Genome Sciences, Inc. |
GCSF-Albumin Fusionsproteine
|
ES2614603T3
(es)
*
|
2002-02-20 |
2017-06-01 |
Emisphere Technologies, Inc. |
Procedimiento de administración de moléculas GLP-1
|
DE60318938T2
(de)
|
2002-03-20 |
2009-01-22 |
Mannkind Corp., Valencia |
Inhalationsgerät
|
US20080260838A1
(en)
*
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
WO2004060310A2
(en)
|
2002-12-31 |
2004-07-22 |
Altus Pharmaceuticals Inc. |
Human growth hormone crystals and methods for preparing them
|
NZ571243A
(en)
*
|
2002-12-31 |
2010-04-30 |
Altus Pharmaceuticals Inc |
Complexes of protein crystals and ionic polymers comprising human growth hormone and protamine
|
JP4887139B2
(ja)
*
|
2003-03-25 |
2012-02-29 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼインヒビター
|
EP1625122A1
(de)
|
2003-05-14 |
2006-02-15 |
Takeda San Diego, Inc. |
Dipeptidylpeptidase-hemmer
|
EP2292254A3
(de)
*
|
2003-06-03 |
2011-12-14 |
Novo Nordisk A/S |
Stabilisierte pharmazeutische Peptidzusammensetzungen
|
KR101293507B1
(ko)
*
|
2003-06-03 |
2013-08-06 |
노보 노르디스크 에이/에스 |
안정화된 약학적 펩티드 조성물
|
JP2007524592A
(ja)
*
|
2003-06-03 |
2007-08-30 |
ノボ・ノルデイスク・エー/エス |
安定化された薬学的ペプチド組成物
|
US7008957B2
(en)
*
|
2003-07-25 |
2006-03-07 |
Sanofi-Aventis Deutschland Gmbh |
Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
|
US7094800B2
(en)
*
|
2003-07-25 |
2006-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Cyanopyrrolidides, process for their preparation and their use as medicaments
|
US7094794B2
(en)
*
|
2003-07-28 |
2006-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
|
DE10335092B3
(de)
*
|
2003-08-01 |
2005-02-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung
|
US8921311B2
(en)
|
2003-08-01 |
2014-12-30 |
Mannkind Corporation |
Method for treating hyperglycemia
|
US7169926B1
(en)
|
2003-08-13 |
2007-01-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
DE602004010206T2
(de)
*
|
2003-08-13 |
2008-10-09 |
Takeda Pharmaceutical Co. Ltd. |
Dipeptidyl Peptidase Inhibitoren.
|
US7678909B1
(en)
|
2003-08-13 |
2010-03-16 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US20060247167A1
(en)
*
|
2003-09-01 |
2006-11-02 |
Novo Nordisk A/S |
Stable formulations of peptides
|
EP1663295A2
(de)
*
|
2003-09-01 |
2006-06-07 |
Novo Nordisk A/S |
Stabilisierte peptidformulierungen
|
JP2007505121A
(ja)
*
|
2003-09-08 |
2007-03-08 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
EP1697342A2
(de)
*
|
2003-09-08 |
2006-09-06 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitoren
|
CA2545034C
(en)
*
|
2003-11-20 |
2013-03-05 |
Novo Nordisk A/S |
Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
|
US7521527B2
(en)
*
|
2003-12-16 |
2009-04-21 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
GLP-1 pharmaceutical compositions
|
US20060286129A1
(en)
*
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
US7732446B1
(en)
|
2004-03-11 |
2010-06-08 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
CA2559302C
(en)
*
|
2004-03-15 |
2012-06-19 |
Takeda Pharmaceutical Company Limited |
6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors
|
US7687638B2
(en)
*
|
2004-06-04 |
2010-03-30 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
WO2006019965A2
(en)
|
2004-07-16 |
2006-02-23 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
DK1786784T3
(da)
|
2004-08-20 |
2011-02-14 |
Mannkind Corp |
Katalyse af diketopiperazinsyntese
|
JP4990142B2
(ja)
|
2004-08-23 |
2012-08-01 |
マンカインド コーポレイション |
薬物送達のためのジケトピペラジン塩、ジケトモルホリン塩、又はジケトジオキサン塩
|
PL1789434T3
(pl)
*
|
2004-08-31 |
2014-07-31 |
Novo Nordisk As |
Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek
|
EP1817048B1
(de)
|
2004-11-12 |
2014-02-12 |
Novo Nordisk A/S |
Stabile formulierungen insulinoptropischer peptide
|
JP2008524331A
(ja)
|
2004-12-21 |
2008-07-10 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼ阻害剤
|
WO2006086769A2
(en)
|
2005-02-11 |
2006-08-17 |
Amylin Pharmaceuticals, Inc. |
Gip analog and hybrid polypeptides with selectable properties
|
US20070004616A1
(en)
*
|
2005-06-30 |
2007-01-04 |
Roland Cherif-Cheikh |
GLP-1 pharmaceutical compositions
|
EA012287B1
(ru)
|
2005-06-30 |
2009-08-28 |
Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик С.А.С. |
Фармацевтическая композиция glp-1
|
PT1942898E
(pt)
*
|
2005-09-14 |
2011-12-20 |
Takeda Pharmaceutical |
Inibidores da dipeptidilpeptidase para o tratamento da diabetes
|
WO2007033266A2
(en)
*
|
2005-09-14 |
2007-03-22 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors for treating diabetis
|
HUE028691T2
(en)
|
2005-09-14 |
2016-12-28 |
Mannkind Corp |
A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients
|
WO2007033265A1
(en)
*
|
2005-09-14 |
2007-03-22 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors for treating diabetis
|
JP5122462B2
(ja)
*
|
2005-09-16 |
2013-01-16 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼ阻害剤
|
TW200745079A
(en)
*
|
2005-09-16 |
2007-12-16 |
Takeda Pharmaceuticals Co |
Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
|
TW200745080A
(en)
*
|
2005-09-16 |
2007-12-16 |
Takeda Pharmaceuticals Co |
Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
|
WO2007102946A2
(en)
*
|
2006-01-23 |
2007-09-13 |
Amgen Inc. |
Crystalline polypeptides
|
AU2007216966C1
(en)
|
2006-02-22 |
2014-03-20 |
Mannkind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2007112368A1
(en)
*
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Preparation of (r)-3-aminopiperidine dihydrochloride
|
RU2419452C2
(ru)
*
|
2006-04-13 |
2011-05-27 |
Ипсен Фарма С.А.С. |
ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ hGLP-1, ЭКСЕНДИНА-4 И ИХ АНАЛОГОВ
|
KR102062824B1
(ko)
*
|
2006-09-13 |
2020-01-07 |
다케다 야쿠힌 고교 가부시키가이샤 |
2-[6-(3-아미노-피페리딘-1-일)-3-메틸-2,4-디옥소-3,4-디하이드로-2h-피리미딘-1-일메틸]-4-플루오로-벤조니트릴의 용도
|
US8324383B2
(en)
|
2006-09-13 |
2012-12-04 |
Takeda Pharmaceutical Company Limited |
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
|
TWI430806B
(zh)
*
|
2006-09-13 |
2014-03-21 |
Smithkline Beecham Corp |
用於投與長效降血糖藥劑之方法
|
TW200838536A
(en)
*
|
2006-11-29 |
2008-10-01 |
Takeda Pharmaceutical |
Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
|
US8093236B2
(en)
|
2007-03-13 |
2012-01-10 |
Takeda Pharmaceuticals Company Limited |
Weekly administration of dipeptidyl peptidase inhibitors
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
KR101736502B1
(ko)
*
|
2007-10-24 |
2017-05-16 |
맨카인드 코포레이션 |
Glp-1에 의한 유해 효과의 예방 방법
|
KR20130123470A
(ko)
*
|
2007-10-24 |
2013-11-12 |
맨카인드 코포레이션 |
활성제의 전달
|
ES2655921T3
(es)
|
2008-06-13 |
2018-02-22 |
Mannkind Corporation |
Un inhalador de polvo seco y sistema para administración de fármacos
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
ES2904623T3
(es)
|
2008-06-20 |
2022-04-05 |
Mannkind Corp |
Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
PL2373681T3
(pl)
|
2008-12-10 |
2017-07-31 |
Glaxosmithkline Llc |
Kompozycje farmaceutyczne albiglutydu
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
JP5918539B2
(ja)
|
2009-01-08 |
2016-05-18 |
マンカインド コーポレイション |
Glp−1を用いる高血糖症の治療方法
|
EP2216042A1
(de)
|
2009-02-09 |
2010-08-11 |
Ipsen Pharma S.A.S. |
GLP1-analoge pharmazeutische Zusammensetzungen
|
EP2405963B1
(de)
|
2009-03-11 |
2013-11-06 |
MannKind Corporation |
Gerät, system und verfahren zur messung von widerstand in einem inhaliergerät
|
WO2010144789A2
(en)
|
2009-06-12 |
2010-12-16 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
WO2011017554A2
(en)
*
|
2009-08-07 |
2011-02-10 |
Mannkind Corporation |
Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
EP2566502A4
(de)
|
2010-05-04 |
2013-10-09 |
Glaxosmithkline Llc |
Verfahren zur behandlung oder prävention von herz-kreislauf-erkrankungen und für herz-kreislauf-schutz
|
KR20130117755A
(ko)
|
2010-06-21 |
2013-10-28 |
맨카인드 코포레이션 |
건조 분말 약물 운반 시스템 및 방법
|
US8927687B2
(en)
|
2010-07-09 |
2015-01-06 |
Amylin Pharmaceuticals, Llc |
Microcrystalline Y receptor agonists
|
CN105667994B
(zh)
|
2011-04-01 |
2018-04-06 |
曼金德公司 |
用于药物药盒的泡罩包装
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
WO2013063160A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
CN108057154B
(zh)
|
2012-07-12 |
2021-04-16 |
曼金德公司 |
干粉药物输送系统和方法
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
JP6523247B2
(ja)
|
2013-03-15 |
2019-05-29 |
マンカインド コーポレイション |
微結晶性ジケトピペラジン粒子の製造方法および乾燥粉末組成物の製造方法
|
CN104107422A
(zh)
*
|
2013-04-16 |
2014-10-22 |
石药集团中奇制药技术(石家庄)有限公司 |
重组胰高血糖素样肽-1受体激动剂的注射用药物组合物
|
EP3021834A1
(de)
|
2013-07-18 |
2016-05-25 |
MannKind Corporation |
Hitzestabile pharmazeutische trockenpulverzusammensetzungen und verfahren
|
EP3030294B1
(de)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflationsvorrichtung
|
BR112016016321A2
(pt)
|
2014-02-18 |
2017-10-03 |
Novo Nordisk As |
Derivados de análogos de glucagon estáveis, seus usos, e composição farmacêutica
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
PL3474820T3
(pl)
|
2017-08-24 |
2024-05-13 |
Novo Nordisk A/S |
Kompozycje glp-1 i ich zastosowania
|
CN108042794B
(zh)
*
|
2018-01-05 |
2022-01-25 |
北京博康健基因科技有限公司 |
重组促胰岛素分泌素的稳定制剂及其制备方法
|
EP4106724A1
(de)
|
2020-02-18 |
2022-12-28 |
Novo Nordisk A/S |
Glp-1-zusammensetzungen und verwendungen davon
|